Clinical Trials Logo

Clinical Trial Summary

Numerous studies Have shown that limb ischemic preconditioning can protect vital organs (including the heart) from ischemia-reperfusion injury,which has a broad application prospect.But its mechanism is still unclear. Evidence showed that humoral mechanisms may play an important role. This study was carried out on the limb ischemic preconditioning in healthy volunteers, collected their serum at different time points before and after treatment,classified and identified the serum proteins during different periods of limb ischemic preconditioning,by using methods including high abundant protein removal,Two-dimensional electrophoresis chromatography and mass spectrometry,then analysed activation and synthesis of the proteins in order to search for the proteins or peptides whose synthesis was activated by ischemic preconditioning. This study will be the first systemic explore of the changes in serum proteins of limb ischemic preconditioning in human body,and lay theoretical basis for the clinical application of limb ischemic preconditioning and for further explore of its humoral mechanism,thus provide clues for searching for protein or peptide having protective effects for organs.


Clinical Trial Description

We aim to assess whether limb ischemic preconditioning protects remote tissue or organs through a humoral mechanism. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01118000
Study type Interventional
Source Sun Yat-sen University
Contact
Status Completed
Phase N/A
Start date September 2009
Completion date March 2010

See also
  Status Clinical Trial Phase
Completed NCT01235286 - Cutaneous Remote Ischemic Preconditioning in Plastic Surgery N/A
Completed NCT00184912 - The Effect of Caffeine on Ischemic Preconditioning N/A
Recruiting NCT03380663 - Conditioning Based Intervention Strategies N/A
Completed NCT03023150 - Ischemic Preconditioning as an Intervention to Improve Stroke Rehabilitation - Froedtert N/A
Completed NCT02981680 - Effect of Remote Ischemic Preconditioning on the Incidence of Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery N/A
Completed NCT00821522 - The Influence of Remote Ischemic Preconditioning on Acute Kidney Injury After Cardiac Surgery Phase 1
Active, not recruiting NCT01164618 - The Biology of Chronic Preconditioning: Genomic and Physiologic Mechanisms of Response Phase 2
Not yet recruiting NCT05957523 - Effects of Remote Ischemic Preconditioning on Components of Peripheral Blood and Gut Microbiome (EMINENT) N/A
Completed NCT04887610 - Factors That Influence Blood Vessel Regulation During Exercise in Humans N/A
Completed NCT05219344 - Tissue Flossing and Lower Limb Neuromuscular Function N/A
Completed NCT00453531 - Model System for Transient Forearm Blood Vessel Dysfunction Phase 1/Phase 2
Not yet recruiting NCT05412888 - Effect of CoQ10 on the Endocrine Function of Skeletal Muscle N/A
Recruiting NCT03900390 - The Study of Potency of Cross-preconditioning to Prevent Ischemic-reperfusion Injury for Heart Transplantation Recipient N/A
Completed NCT02411266 - Preconditioning With Limb Ischemia for Subarachnoid Hemorrhage N/A
Completed NCT02666235 - Remote Ischaemic Conditioning and Coronary Endothelial Function (RIC-COR) Phase 2
Terminated NCT01743937 - A Trial Comparing the Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans Phase 4
Completed NCT04016857 - Remote Ischemic Preconditioning During Lower Limb Revascularization N/A
Not yet recruiting NCT05653505 - Remote Ischemic Conditioning Combined With Endovascular Stenting for Symptomatic Intracranial Atherosclerotic Stenosis
Completed NCT02965547 - Remote Ischemic Preconditioning of Dynamic Cerebral Autoregulation in Healthy Adults N/A
Completed NCT05350683 - Effect of Remote Ischemic Preconditioning on the Incidence of Contrast Induced Nephropathy in Patients Undergoing EVAR Phase 2